Measurement of proliferation activities in human tumor models: A comparison of flow cytometric methods

Radiation Oncology Investigations

Volumn 6, Issue 3, 1998, Pages 120-127

  Keng, Peter C ^a   Siemann, Dietmar W ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Cell growth; Flow cytometry; Proliferating cell nuclear antigen; Tumor cell line; Tumor markers

Indexed keywords

ACRIDINE ORANGE; BROXURIDINE; DNA; KI 67 ANTIGEN; THYMIDINE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; STAINING; TUMOR GROWTH; XENOGRAFT;

EID: 0031813016     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1520-6823(1998)6:3<120::aid-roi2>3.0.co;2-%23     Document Type: Article

References (34)

1. Hall EJ (ed): Radiobiology for the Radiologist, 4th ed. Philadelphia: J.B. Lippincott, 1994.
2. Weichselbaum RR, Dahlberg, W, Little JB: Inherently radioresistant cells exist in some human tumors. Proc Natl Acad Sci USA 82:4732-4735, 1985.
3. Lees-Miller SP, Godbout R, Chan DW, Weinfeld M, Day RS 3rd, Barron GM, Allalunis-Turner J: Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science 267:1183-1185, 1995.
4. Sartorelli AC, Lazo JS, Bertino JR (eds): Molecular Actions and Targets for Cancer Chemotherapeutic Agents. New York: Academic Press, 1981.
5. Heppner GH, Miller BE: Tumor heterogeneity: Biological implications and therapeutic consequences. Cancer Metastasis Rev 2:5-23, 1983.
6. Siemann DW, Keng PC: Cell-cycle phase and proliferation state-dependent radiation and chemotherapeutic agent toxicity in vivo. Semin Radiat Oncol 3:99-104, 1993.
7. Kovarik J, Skry GD, Mikel J, Svoboda VH: Changes of Ki67 index of various tumors during radiation therapy. Neoplasma 43:89-92, 1996.
8. Begg AC: Prediction of repopulation rates and radiosensitivity in human tumours. Int J Radiat Biol 65:103-108, 1994.
9. Horiot JC, Begg AC, Le Fur R, Schraub S, van den Bogaert W, van Glabbeke M, Pierart M: Present status of EORTC trials of hyperfractionated and accelerated radiotherapy on head and neck carcinoma. Recent Results. Cancer Res 134:111-119, 1994.
10. Scagliotti GV, Micela M, Gubetta L, Leonardo E, Cappia S, Borasio P, Pozzi E: Prognostic significance of Ki67 labelling in resected non small lung cancer. Eur J Cancer 29A:363-365, 1993.
11. Meyer JS, Friedman E, McCrate MM, Bauer WC: Prediction of early course of breast carcinoma by thymidine labeling. Cancer 51:1879-1886, 1983.
12. Darzynkiewicz Z, Traganos F, Sharpless T, Melamed MR: Lymphocyte stimulation: A rapid multiparameter analysis. Proc Natl Acad Sci USA 73:2881-2884, 1976.
13. Dolbeare F, Gratzner H, Pallavicini MG, Gray JW: Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci USA 80:5573-5577, 1983.
14. Keng PC, Allalunis-Turner J, Siemann DW: Evaluation of cell subpopulations isolated from human tumor xenografts by centrifugal elutriation. Int J Radiat Oncol Biol Phys 18:1061-1067, 1990.
15. Dethlefesen LA: In quest of the quaint quiesent cells. In Meyn RE, Withers HR (eds): Radiation Biology in Cancer Research. New York: Raven Press, pp. 415-435, 1980.
16. Iatropoulos MJ, Williams GM: Proliferation markers. Exp Toxicol Pathol 48:175-181, 1996.
17. Takasaki Y, Deng JS, Tan EM: A nuclear antigen associated with cell proliferation and blast transformation. J Exp Med 154:1899-1909, 1981.
18. Celis JE, Madsen P, Nielsen S, Celis A: Nuclear patterns of cyclin (PCNA) antigen distribution subdivide S-phase in cultured cells-some applications of PCNA antibodies. Leuk Res 10:237-249, 1986.
19. Gerdes J: An immunohistological method for estimating cell growth fractions in rapid histopathological diagnosis during surgery. Int J Cancer 35:169-171, 1985.
20. Celis JE, Bravo R, Larsen PM, Fey SJ: Cyclin: A nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells. Leuk Res 8:143-157, 1984.
21. Leers MP, Theunissen PH, Ramaekers FC, Schutte B: Multi-parameter flow cytometric analysis with detection of the Ki67-Ag in paraffin embedded mammary carcinomas. Cytometry 27:283-289, 1997.
22. Glasova M, Konikova E, Kusenda J, Babusikova O: Flow cytometric detection of some activation and proliferation markers in human hematopoietic cell lines. Neoplasma 43:381-388, 1996.
23. Liu YC, Marraccino RL, Keng PC, Bambara RA, Lord EM, Chou WG, Zain SB: Requirement for proliferating cell nuclear antigen expression during stages of the Chinese hamster ovary cell cycle. Biochemistry 28: 2967-2974, 1989.
24. Tsurusawa M, Aoyama M, Saeki K, Fujimoto T: Cell cycle kinetics in childhood acute leukemia studied with in vitro bromodeoxyuridine labeling, Ki67-reactivity, and flow cytometry. Leukemia 9:1921-1925, 1995.
25. Liesveld JL, Keng PC, Rowe JM, DiPersio JF, Abboud CN: Effects of GM-CSF on Ki67 expression and cell cycle traverse in acute myelogenous leukemia specimens and cell lines. Leuk Res 18:609-616, 1994.
26. Schwarting R, Gerdes J, Niehus J, Jaeschke L, Stein H: Determination of the growth fraction in cell suspensions by flow cytometry using the monoclonal antibody Ki-67. J Immunol Methods 90:65-70, 1986.
27. Pich A, Ponti R, Valente G, Chiusa L, Geuna M, Novero D, Palestro G: MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas. J Clin Pathol 47:18-22, 1994.
28. Toolan HW: Transplantable human neoplasms maintained in cortisone-treated laboratory animals: H.S. #1, HEp #1, HEp #2, HEp #3, and H.Emb.Rh. #1. Cancer Res 14:660-667, 1954.
29. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP: In vitro cultivation of human tumors: Establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 51:1417-1423, 1973.
30. Keng PC: Assessing radiation sensitivity of human tumor subpopulations by proliferating status, DNA content and monoclonal antibodies. Proceedings of the 8th International Congress. Radiat Res 2:837-842, 1987.
31. Luk CK, Keng PC, Sutherland RM: Radiation response of proliferating and quiescent subpopulations isolated from multicellular spheroids. Br J Cancer 54:25-32, 1986.
32. Patsouris E, Stocker U, Kallmeyer V, Keiditsch E, Mehraein P, Stavrou D: Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors. Anticancer Res 8:537-544, 1988.
33. Schrape S, Jones DB, Wright DH: A comparison of three methods for the determination of the growth fraction in non-Hodgkin's lymphoma. Br J Cancer 55:283-286, 1987.
34. Sasaki K, Matsumura K, Tsuji T, Shinozaki F, Takahashi M: Relationship between labeling indices of Ki67 and BrdUrd in human malignant tumors. Cancer 62:989-993, 1988.